Clinical Platform Inc. announced that it will receive an equity round of funding on March 13, 2018. The transaction will include participation from existing investors, MTI Ltd. (TSE:9438) and MediPal Holdings Corporation (TSE:7459). Post the closing, the investors will hold 50.86% and 10.14% stake respectively in the transaction.

MTI Ltd. (TSE:9438) will also acquire shares from existing shareholders of the company. The company and the investors entered into a capital alliance on the same date.